$CHGA Balance Sheet | Understand Stock

$CHGA

$1.55 +$0.09 (6.16%) Close

$CHGA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
CURRENT ASSETS:
Cash
Rent receivable
Rent receivable - related party
Deferred financing costs, net
Prepaid professional fees
Receivable from sale of equity method investment, current portion
Receivable from sale of equity method investment
Prepaid expense and other current assets
Current assets of discontinued operations
Total Current Assets

NON-CURRENT ASSETS:
Rent receivable - noncurrent portion
Operating lease right-of-use assets, net
Receivable from sale of equity method investment, noncurrent portion
Property and equipment, net
Investment in real estate, net
Intangible assets, net
Goodwill
Equity method investments, net
Series B Convertible Preferred Stock
Total equity method investments, net
Advances for equity interest purchase
Other non-current assets
Security deposit
Deferred leasing costs
Non-current assets of discontinued operations
Total Non-current Assets
Total Assets

CURRENT LIABILITIES:
Accrued professional fees
Accrued research and development fees
Accrued payroll liability and compensation
Accrued litigation settlement
Accrued liabilities and other payables
Accrued liabilities and other payables - related parties
Related Party
Total accrued liabilities and other payables - related parties

Accrued liabilities and other payables - related party
Operating lease obligation
Note payable - related party
Advance from sale of noncontrolling interest - related party
Related Party
Total advance from sale of noncontrolling interest - related party
Advance from pending sale of noncontrolling interest - related party
Equity method investment payable
Advance from pending sale of subsidiary - related party
Related Party
Total advance from pending sale of subsidiary - related party
Derivative liability
Stock subscription liability
Bridge loan payable, net
Convertible note payable, net
Note payable, net
Current liabilities of discontinued operations
Total Current Liabilities

NON-CURRENT LIABILITIES:
Operating lease obligation, noncurrent portion
Note payable - related party
Accrued litigation settlement - noncurrent portion
Note payable, net - noncurrent portion
Loan payable - related party
Related Party
Total loan payable - related party
Non-current liabilities of discontinued operations
Total Non-current Liabilities
Total Liabilities

Preferred stock value
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Preferred stock, value
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
EQUITY:
Preferred stock, value issued
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Series D Convertible Preferred Stock
Series D Convertible Preferred Stock
Series E Convertible Preferred Stock
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Total preferred stock, value issued

Series B Convertible Preferred Stock, 11,000 and 0 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively. Liquidation preference $11 million at March 31, 2023
Common stock, $0.0001 par value; 100,000,000 shares authorized; 13,680,790 shares issued and 13,677,323 shares outstanding at June 30, 2026; 4,857,476 shares issued and 4,854,009 shares outstanding at December 31, 2025
Common stock to be issued
Series B Convertible Preferred Stock
Total common stock to be issued

Additional paid-in capital
Less: common stock held in treasury, at cost; 3,467 shares at June 30, 2026 and December 31, 2025
Accumulated deficit
Statutory reserve
Accumulated other comprehensive loss
Total Change Agents Corporation stockholders’ equity
Total Equity
Total Liabilities and Equity

Comments